SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL
Cavender MA, Norhammar A, CVD-REAL Investigators and Study Group.
KEYWORDS
CVD-REAL; cardiovascular disease; heart failure; sodium-glucose co-transporter-2 inhibitors